Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is one of the
leading causes of cancer-related deaths worldwide. Despite advances in medicine, it is still …

The conventional method used to obtain a tumor biopsy for hepatocellular carcinoma (HCC)
is invasive and does not evaluate dynamic cancer progression or assess tumor …

Liver cancer (hepatocellular carcinoma [HCC]) is a fatal cancer worldwide and often is
detected at an advanced stage when treatment options are very limited. This drives the …

Circulating free tumor DNA (ctDNA) is DNA released from necrotic or apoptotic tumor cells
into the bloodstream. Absolute levels of ctDNA, as well as genetic mutations and epigenetic …

As one of the most common malignant tumors worldwide, hepatocellular carcinoma (HCC) is
known for its poor prognosis due to diagnosis only in advanced stages. Nearly 50% of the …

Liver cancer is the second-most common cause of cancer-related mortality worldwide, and
hepatocellular carcinoma (HCC) accounts for 90% of all cases. According to the current …

Hepatocellular carcinoma (HCC) is one of the most prevalent forms of cancer worldwide.
Therefore, it is essential to diagnose and treat HCC patients promptly. As a novel discovery …

Background Globally, liver cancers are the second most lethal malignancy after lung cancer
(0.83 million deaths in 2020). Hepatocellular carcinoma (HCC) is the predominant type of …

Hepatocellular carcinoma (HCC) is one of the most common cancers and a leading cause of
death worldwide. Due to latent liver disease, late diagnosis, and nonresponse to systemic …

With the emergence of novel targeted therapeutic options in early-stage and advanced-
stage malignancies, researchers have shifted their focus on developing personalized …